Active surveillance no longer "preferred" management for low-risk prostate cancer? Really NCCN??! Jeez

This one really slipped under the radar when the National Comprehensive Cancer Centre Network (NCCN) Prostate Cancer Guideline Panel released their updated guidelines a few weeks ago. That is until Dr Dan Lin mentioned it to Dr Matt Cooperberg, who promptly flagged it to his very large Twitter following. And what a reaction! Almost universally panned by the urological community, especially advocates for active surveillance (AS), who have long despaired at the low rates of AS uptake in the US...